This seminar is unfortunately postponed due to illness – new date not decided yet

Philip Gribbon & Päivi Östling

The fourth SciLifeLab COVID-19 seminar this spring starts with  Philip Gribbon, Head of Discovery Research, Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany, talking about ” Compound repurposing in COVID-19, target and phenotypic-based approaches“.
The second talk, “Exploring the morphology of the host cell to open new possibilities in drug repurposing” will be given by  Päivi Östling, Department of Oncology-Pathology, Karolinska Institutet

Moderator: Annika Jenmalm Jensen, SciLifeLab Infrastructure Director

Schedule

15:15- 16:00	Compound repurposing in COVID-19, target and phenotypic-based approaches  Philip Gribbon Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany
16:00-16:45	Exploring the morphology of the host cell to open new possibilities in drug repurposing Päivi Östling Department of Oncology-Pathology, Karolinska Institutet

Related Events

• 

  Towards the routine data collection from pico-gram crystals

  March 28 @ 12:00 – 13:00 CEST

  Hybrid Event
• 

  Regulation of protein disaggregation in primates 

  March 28 @ 13:00 – 14:00 CEST
• 

  Exhibition in Navet at BMC

  March 29 @ 09:00 – March 30 @ 15:00 CEST